Mycronic AB (publ)
MICLF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $180,983 | $2,066,000 | $2,142,000 | $2,059,000 |
| % Growth | -91.2% | -3.5% | 4% | – |
| Cost of Goods Sold | $97,110 | $963,000 | $832,000 | $1,055,000 |
| Gross Profit | $83,873 | $1,103,000 | $1,310,000 | $1,004,000 |
| % Margin | 46.3% | 53.4% | 61.2% | 48.8% |
| R&D Expenses | $23,722 | $242,000 | $222,000 | $216,000 |
| G&A Expenses | $0 | $114,000 | $106,000 | $102,000 |
| SG&A Expenses | $23,933 | $286,000 | $281,000 | $274,000 |
| Sales & Mktg Exp. | $0 | $172,000 | $175,000 | $172,000 |
| Other Operating Expenses | $0 | $0 | $0 | -$12,000 |
| Operating Expenses | $47,655 | $528,000 | $503,000 | $478,000 |
| Operating Income | $36,218 | $575,000 | $807,000 | $526,000 |
| % Margin | 20% | 27.8% | 37.7% | 25.5% |
| Other Income/Exp. Net | -$8,790 | -$1,000 | -$21,000 | $17,000 |
| Pre-Tax Income | $27,428 | $574,000 | $786,000 | $543,000 |
| Tax Expense | $4,448 | $128,000 | $165,000 | $78,000 |
| Net Income | $22,980 | $446,000 | $620,000 | $460,000 |
| % Margin | 12.7% | 21.6% | 28.9% | 22.3% |
| EPS | 0.12 | 2.28 | 3.18 | 2.36 |
| % Growth | -94.7% | -28.3% | 34.7% | – |
| EPS Diluted | 0.12 | 2.28 | 3.18 | 2.36 |
| Weighted Avg Shares Out | 195,270 | 195,614 | 97,590 | 97,665 |
| Weighted Avg Shares Out Dil | 195,270 | 195,614 | 97,652 | 97,665 |
| Supplemental Information | – | – | – | – |
| Interest Income | $424 | $6,000 | $10,000 | $16,000 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $9,107 | $0 | $0 | $10,000 |
| EBITDA | $36,536 | $575,000 | $807,000 | $536,000 |
| % Margin | 20.2% | 27.8% | 37.7% | 26% |